Everolimus product-specific bioequivalence guidance

Keywords Bioequivalence, generics, everolimus
Description This document provides product-specific guidance on the demonstration of the bioequivalence of everolimus.
Abbreviations
  • BCS Classification: Biopharmaceutics Classification System
  • AUC0-t: area under the plasma concentration curve from administration to last observed concentration at time t
  • AUC0-72: area under the plasma concentration curve from administration to last observed concentration at 72 hours
  • Cmax: maximum plasma concentration


Document history

First version
Current version

Adopted guideline

 

PDF iconOverview of comments

 

PDF iconDraft guideline

Published: 03/01/2017

 

Published: 03/01/2017

 

Published: 02/05/2016

 

Related content


How useful was this page?

Add your rating